COVID-19 rebound

RELAPSE of COVID-19 symptoms or a new positive viral test following a period of improvement and having tested negative for SARS-CoV-2 (https://emergency.cdc.gov/han/2022/pdf/CDC_HAN_467.pdf). COVID-19 rebound symptoms may develop with or without COVID-19 DRUG TREATMENT (e.g., with PAXLOVID or MOLNUPIRAVIR) due to undetectable amount of virus presumably remaining from the initial infection instead of REINFECTION.

Also Known As:

COVID-19 recrudescence; COVID-19 relapse

Infections: 526564
- Virus Diseases: 41777
  - Viral Pneumonia: 577
    - COVID-19: 109434
      - COVID-19 rebound: 20
  - RNA Virus Infections: 303
    - Nidovirales Infections
      - Coronaviridae Infections: 1
        Coronavirus Infections: 1279
        COVID-19: 109434
        COVID-19 rebound: 20
- Respiratory Tract Infections: 14082
  - Pneumonia: 52735
    - Viral Pneumonia: 577
      - COVID-19: 109434
        COVID-19 rebound: 20
Respiratory Tract Diseases: 6015
- Lung Diseases: 22246
  - Pneumonia: 52735
    - Viral Pneumonia: 577
      - COVID-19: 109434
        COVID-19 rebound: 20
- Respiratory Tract Infections: 14082
  - Pneumonia: 52735
    - Viral Pneumonia: 577
      - COVID-19: 109434
        COVID-19 rebound: 20
Signs and Symptoms Pathological Conditions
- Pathologic Processes: 10023
  - Disease Attributes: 18
    - Recurrence
      - COVID-19 rebound: 20

Recurrence

Disease Context: Research Results